Table 7.
Generalized estimating equations (GEE) regarding clinical symptoms and quality of life at baseline, and 12-week follow-up (total N=33 patients in the GEE; 29 contributed with complete data from baseline to follow-up).
| Measure | Pre, mean (SE) | Post, mean (SE) | Coefficient | Z | P | Cohen da (95% CI) |
| BAI | 20.54 (1.7) | 15.82 (1.8) | -4.72 | -2.88 | .004 | 0.45 (0.1 to 0.8) |
| GAD-7 | 10.35 (0.8) | 9.15 (0.9) | -1.20 | -1.77 | .077 | 0.20 (-0.1 to 0.5) |
| MADRS-S | 20.96 (1.3) | 18.18 (1.4) | -2.78 | -2.61 | .009 | 0.32 (0.0 to 0.6) |
| PHQ-9 | 13.32 (0.9) | 9.19 (1.0) | -4.13 | -3.68 | <.001 | 0.69 (0.2 to 1.1) |
| QOLI | -0.37 (0.3) | 0.03 (0.3) | 0.40 | 2.12 | .034 | -0.18 (-0.4 to 0.1) |
aEffect sizes (Cohen d) were calculated on observed data.